Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease

Conclusions The results of our study suggest that albuterol showed a good safety profile as an adjunctive treatment in our IOPD cohort, although the benefits are limited.
Source: Molecular Genetics and Metabolism Reports - Category: Genetics & Stem Cells Source Type: research